Company KPI Data Charting Tools Stock Screener Industry Financials Time Series Tables

Login Start for Free

Account Settings Subscription API Usage API Keys Billing Log Out

Research Tools

Company KPI Data
Charting Tools
Stock Screener
Industry Financials
Time Series Tables

Login Start for Free

Overview
Financial Statements
KPIs & Operating Metrics
Estimates
Dividends
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

KPIs & Operating Metrics(New)

Breakdown Of Assets Employee Statistics Gastroenterology Revenue By Category Gastroenterology Revenue By Category Annual Hereditary Angioedema By Category Annual Neuroscience Revenue By Category Neuroscience Revenue By Category Annual Non Current Assets By Geography Annual Non Gaap Profitability Non Gaap Profitability %Non Gaap Profitability Annual Non Gaap Profitability Annual %Oncology Revenue By Category Oncology Revenue By Category Annual Opex As A % Of Total Revenue %OPEX Segregation Other Revenue By Category Other Revenue By Category Annual Pdt Immunology Revenue By Category Pdt Immunology Revenue By Category Annual Property, Plant And Equipment, Net Breakdown Rare Genetics And Other Revenue By Category Rare Hematology Revenue By Category Rare Hematology Revenue By Category Annual Rare Metabolic Revenue By Category Annual Remaining Performance Obligations Revenue By Category Rare Diseases Revenue By Region Revenue By Region %Revenue By Region Annual Revenue By Region Annual %Revenue By Therapeutic Area Revenue By Therapeutic Area %Revenue By Therapeutic Area Annual Revenue By Therapeutic Area Annual %Revenue By Type Of Good Or Service Revenue By Type Of Good Or Service %Revenue By Type Of Good Or Service Annual Revenue By Type Of Good Or Service Annual %

Balance Sheet

Accounts Payables Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Enterprise Value Market Cap to FCF Market Capitalization Price Price to Earnings Price to Sales

Growth Metrics

Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Income Statement

Consolidated Net Income Cost of Revenue EBIT EBITDA EBT Equity Income Gross Profit Income from Continuing Operations Income from Non-Controlling Interests Income towards Parent Company Interest & Investment Income Interest Expenses Interest Expenses Net Income towards Common Stockholders Operating Expenses Operating Income Profit After Tax Revenue Selling, General & Administrative Shares Outstanding Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions Tax Rate Tax Rate

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Receivables - Net Receivables - Other Receivables Refunds Shares Outstanding Shares Outstanding

Ratios

Assets Average Debt Ratio Debt to Equity EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio Gross Margin Interest Coverage Ratio Inventory Average Invested Capital Net Margin Operating Margin Return on Assets Return on Sales Times Interest Earned

Takeda Pharmaceutical (TAK) Selling, General & Administrative (2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us
API Documentation

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount